Exchange: NYSE
Industry: Pharmaceuticals & Biotechnology
Last Trade: 4:04 PM ET 4/5/2013
Last 10 Quotes:
What's This?
| Most Recent Quarter ($) | Same Quarter Last Year ($) | % Change | |
| EPS, Pro Forma | 0.17 | 0.25 | -30.45 |
| EPS, GAAP | 0.17 | 0.25 | 0.25 |
| Consensus Estimate | 1.00 | 0.90 | 11.83 |
| Trailing 12 Months | Year-Earlier Period | % Change | |
| EPS, Pro Forma | 0.93 | 1.10 | -15.48 |
| EPS, GAAP | 0.92 | 1.03 | -11.32 |
| Consensus Estimate | 3.60 | 3.54 | 1.50 |
| GSK | Industry Average | |
| P/E (TTM) | 15.88 | NA |
| P/E (Forward) | 13.18 | NA |
| PEG Ratio | 1.69 | 2.20 |
| Price/Sales | 2.82 | 18.91 |
| Beta | 0.26 | 0.70 |
| 3:49 AM | 4/5/2013 | Roche Agrees To Release All Tamiflu Trial Data |
| 9:26 AM | 4/3/2013 | GlaxoSmithKline Starts Study of Benlysta in Patients with Vasculitis |
| 2/21/2013 | Novo's Pain Means Sanofi Shares Gain (Barrons.com) |
| 2/21/2013 | The Top Dividend Stocks from Warren Buffett and Berkshire Hathaway (24/7 Wall St) |
| 2/14/2013 | Berkshire Hathaway and Buffett Make Many Portfolio Changes For 2013 (24/7 Wall St) |
| 1/25/2013 | BofA/Merrill Lynch: Three Reasons to Own Stocks Now (GSK, BMY, SNY, ABBV, PM, MSFT, INTC, BP, KRFT, GE) (24/7 Wall St) |
| 1/14/2013 | More Hope for Cancer Vaccines in 2013 (UBS, GSK, DNDN, AMGN) (24/7 Wall St) |
| 1/11/2013 | Best Big Pharma Bets for 2013 (Barrons.com) |
| 12/13/2012 | Mayne Pharma Seeks $19 Million to Fund GlaxoSmithKline Deal (WSJ.com) |
